Guest guest Posted May 29, 2005 Report Share Posted May 29, 2005 There has been 29 more votes since the last summary was prepared (238 --> 267). The top rank one that have good characteristic (better change of improving AND less risk of a major adverse reaction than picking a random protocol). i.e. > 70% chance of gain < 1.0 for risk 1) Salt/Vitamin C 2) FWIW (No Deficiency Left Behind) 3) Alfred Blasi 4) Nicholson 5) Teitelbaum 6) Hemex The two protocols are strongly discouraged (more chance of LOSS AND more chance of a major adverse reaction than picking a random protocol) < 70% chance of gain > 1.0 for risk 1) Marshall Protocol 2) Ampligen Summary is at: http://www.lassesen.com/cfids/protocols.com Details are at: http://lassesen.com/cfids/raw_survey_results.htm (exact poll talleys and worksheet) Usual Disclaimers: 1) These are self-reporting evaluation of subjective experiences 2) No verification of compliance with the protocol or meeting CFIDS criteria was done 3) Any registered Member may vote at: /polls. If you have tried any of these protocols, please share your experience by voting. FEEL FREE TO FORWARD OR REPOST As a FYI: I also notice that http://cfsgroups.org/discussion/view_category.php? id=3 has created polls on many of the same protocols and a few others. Looking at http://cfsgroups.org/reports/ , I see the ability to ****cross comparison**** between polls (something not available with polls). If you are seriously interested in sharing experiences, I would advocate doing the polls on their site. If enough people do these polls, the ability to infer your probable experience with a protocol or a drug or a supplement prior to doing it is possible. It's an ambitious project because it needs a lot of votes to be successful. Ken Lassesen, M.S. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.